Author Affiliations: Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Brachioradial pruritus (BRP) is characterized by intractable itching localized to the dorsolateral aspects of the arms.1,2 Aprepitant (Emend; Merck & Co Inc), approved in 2003 for chemotherapy-induced nausea and vomiting, has been used successfully to treat patients with chronic pruritus,3,4 but to our knowledge, its use in BRP has not yet been reported.
Ally MS, Gamba CS, Peng DH, Tang JY. The Use of Aprepitant in Brachioradial Pruritus. JAMA Dermatol. 2013;149(5):627–628. doi:10.1001/jamadermatol.2013.170
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.